Frequency Exchange rehashes summer work

Executive Summary

• Frequency Exchange Corp. reported strong summer 2025 activities, highlighting expanded investor interest, strategic global partnerships, and participation in health sector leadership forums.
• The company secured multiple key distribution and licensing agreements, including an exclusive license with MG Tech to embed its "Nikki" wellness technology into the "Playflex" wearable, a retail distribution deal with Ripple for North America and international markets, and a regional distribution agreement with Reviva for the Middle East.
• The company increased its non-brokered private placement from $1.5 million to $2 million, with funds allocated to management expansion, technology upgrades, marketing, working capital, and inventory scaling.

Key Details

• MG Tech Partnership: Signed an exclusive license agreement to embed the "Nikki" wellness technology into "Playflex," a wearable solution for athletic performance, in-game communication, and biometric tracking.
  • Advisory Board Appointments: Melvin Bratton (NFL agent), Darin Graham (NFL trainer), and Tandon Doss (Super Bowl champion) joined the advisory board.
  • Market Support: Collaboration with Cam Neely (NHL) and Dr. Keith Pyne (MLB) to support market development in the US sports sector.
• Ripple Distribution Partnership: Entered into a retail distribution agreement with Ripple, a channel development partner specializing in wellness products.
  • Scope: Support for retail growth in North America and international markets via structured sales programs and operational management.
• Reviva Partnership (Middle East): Signed a regional distribution agreement with Reviva, a UAE-based firm specializing in health and lifestyle solutions.
  • Significance: Nikki will be one of the first frequency-based wearable wellness technologies introduced in the Middle East.
• Private Placement Update: Increased the previously announced non-brokered private placement from $1.5 million to $2 million.
  • Use of Proceeds: Expansion of management and sales teams, technology upgrades, marketing, working capital, inventory scaling, reducing outstanding liabilities, and supporting demand for Fremedica's patented technology rights in general wellness applications.
• Conference Participation: Presented "Nikki" at Healthy America 2025 and the Patient First National Conference, focusing on policy-forward engagement with public and private sector stakeholders.

Notable Quotes

• Stephen Davis, CEO: "We are building a capital-efficient, IP-driven [intellectual property] platform for measurable health outcomes. The partnerships and distribution agreements we secured this summer signal growing confidence in the scalability and commercial strength of our frequency-based wellness platform."
• Stephen Davis, CEO: "Integrating Nikki into Playflex enhances its real-time athletic tracking with personalized wellness programming. This is a model for embedding our technology into performance environments with measurable need and scale potential."
• Stephen Davis, CEO: "We are aligning with experienced operators who can scale our wellness offerings through proven sales infrastructure. Ripple adds real-world execution strength behind our distribution strategy."
• Ali Nached, Founder of Reviva: "Nikki aligns with the UAE's emphasis on innovation, aesthetic and evidence-based personal health support."
• Stephen Davis, CEO: "We are seeing early traction in markets where consumers expect innovation and quality. Our agreement with Reviva reflects both market interest and our ability to deliver a differentiated technology that meets the demand."